These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34504613)

  • 1. MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2.
    Feng Q; Wu Q; Liu X; Xiong Y; Li H
    Exp Ther Med; 2021 Oct; 22(4):1168. PubMed ID: 34504613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.
    Zhou Z; Li Z; Shen Y; Chen T
    Exp Ther Med; 2021 Dec; 22(6):1403. PubMed ID: 34675996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2.
    Feng Q; Wu Q; Liu X; Xiong Y; Li H
    Exp Ther Med; 2017 Jun; 13(6):3167-3174. PubMed ID: 28587390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.
    Lv YF; Yan GN; Meng G; Zhang X; Guo QN
    Sci Rep; 2015 Aug; 5():12999. PubMed ID: 26265454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction].
    Onco Targets Ther; 2021; 14():4637-4638. PubMed ID: 34511931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
    Zhang Y; Wang J; An W; Chen C; Wang W; Zhu C; Chen F; Chen H; Zheng W; Gong J
    Technol Cancer Res Treat; 2019; 18():1533033819854132. PubMed ID: 31138033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.
    Wang Z; He R; Xia H; Wei Y; Wu S
    Exp Ther Med; 2021 Sep; 22(3):978. PubMed ID: 34349849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.
    Liu J; Chen B; Yue B; Yang J
    Exp Ther Med; 2021 Sep; 22(3):977. PubMed ID: 34349848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.
    Wu Q; Zhou W; Feng Q; Liu X; Xiong Y; Li H
    Exp Ther Med; 2021 Nov; 22(5):1258. PubMed ID: 34603526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.
    Wang Z; Zheng C; Jiang K; He J; Cao X; Wu S
    Exp Ther Med; 2021 Dec; 22(6):1409. PubMed ID: 34676002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.
    Zhang K; Zhang Y; Ren K; Zhao G; Yan K; Ma B
    Oncol Rep; 2014 Nov; 32(5):2143-9. PubMed ID: 25190211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.
    Lv D; Zhen Z; Huang D
    Exp Ther Med; 2022 Jul; 24(1):475. PubMed ID: 35761805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-153 functions as a tumor suppressor in gastric cancer via targeting Kruppel-like factor 5.
    Ouyang Y; Yuan W; Qiu S
    Exp Ther Med; 2022 Apr; 23(4):266. PubMed ID: 35251332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
    Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
    Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
    Zhu Z; Tang J; Wang J; Duan G; Zhou L; Zhou X
    PLoS One; 2016; 11(3):e0150026. PubMed ID: 27019355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: mir-204-5p Acts as a Tumor Suppressor by Targeting DNM2 in Osteosarcoma Cells.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9827523. PubMed ID: 36718171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
    Huang B; Huang M; Li Q
    Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies.
    Nakagawa M; Kitabayashi I
    Cancer Sci; 2018 Aug; 109(8):2342-2348. PubMed ID: 29845708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.